Kees Okkersen

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Michael Flower, Vilija Lomeikaite, Marc Ciosi et al. · Brain · 2019 · 169 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

Kees Okkersen, Cecilia Jimenez‐Moreno, Stephan Wenninger et al. · The Lancet Neurology · 2018 · 121 citations · Full text

Medicine, Rehabilitation Medicine, Physical Activity +11

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort

Sarah A. Cumming, Cecilia Jimenez‐Moreno, Kees Okkersen et al. · Neurology · 2019 · 89 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

MPZL2, Encoding the Epithelial Junctional Protein Myelin Protein Zero-like 2, Is Essential for Hearing in Man and Mouse

Mieke Wesdorp, Silvia Murillo‐Cuesta, Theo Peters et al. · The American Journal of Human Genetics · 2018 · 49 citations · Full text

Life Sciences, Neurobiology, Neuroscience +10

Structural white matter networks in myotonic dystrophy type 1

Maud van Dorst, Kees Okkersen, Roy P. C. Kessels et al. · NeuroImage Clinical · 2018 · 31 citations · Full text

Medicine, Neurology, Neuroscience +17